Ardsley Advisory Partners LP Cerus Corp Transaction History

Ardsley Advisory Partners LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.25 - $8.56 $367,500 - $599,200	-70,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.84 - $4.86 $38,400 - $48,600	-10,000 Reduced 12.5%	70,000 $295,000
Q2 2017 Sep 21, 2017	BUY	N/A	80,000	80,000 $200,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.